Skip to main content

Growth Patterns and Skeletal Maturation During Sex Steroid Suppression and Reactivation in Central Precocious Puberty

  • Chapter
GnRH Analogues in Cancer and Human Reproduction

Abstract

Children with centrally-mediated precocious puberty (CPP) undergo a sequence of hypothalamic-pituitary-gonadal activation which appears to be normal except for the age of its occurrence. Premature exposure to gonadal steroids in children with precocity is associated with an acceleration of linear growth identical to the adolescent growth spurt save for the age of its occurrence. Skeletal maturation is even more markedly advanced by this early exposure to gonadal steroids in these patients, often leading to early epiphyseal fusion and compromised adult stature [1–3]

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Jolly, H. Sexual Precocity. Springfield, IL, Charles C. Thomas, 1955, 1 276

    Google Scholar 

  2. Thamdrup, E (1961). Precocious sexual development: a clinical study of 100 children. Springfield, IL, Charles C Thomas, 44 63

    Google Scholar 

  3. Sigurjonsdottir, TJ, Hayles, AB (1968). Precocious puberty. A report of 96 cases. Am J Dis Child, 115, 309

    PubMed  CAS  Google Scholar 

  4. Crowley, WF Jr, Comite, F, Vale, W, Rivier, J, Loriaux, DL, and Cutler, GB Jr (1981). Therapeutic use of pituitary desensitization with a long-acting LHRH agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab, 52, 370

    Article  PubMed  Google Scholar 

  5. Comite, F, Cutler, GB Jr, Rivier, J, Vale, WW, Loriaux, DL, and Crowley, WF Jr (1981). Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone: A preliminary report. N Engl J Med, 305, 1546

    Article  PubMed  CAS  Google Scholar 

  6. Mansfield, MJ, Beardsworth, DE, Loughlin, JS, Crawford, JD, Bode, HH, Rivier, J, Vale, W, Kushner, DC, Crigler, JF and Crowley, WF Jr (1983). Long-term treatment of central precocious puberty with a long- acting analogue of luteinizing hormone-releasing hormone. N Engl J Med, 309, 1286

    Article  PubMed  CAS  Google Scholar 

  7. Boepple, PA, Mansfield, MJ, Wierman, ME, Rudiin, CR, Bode, HH, Crigler, JF Jr, Crawford, JD and Crowley, WF Jr (1986). Use of a potent, long-acting agonist of gonadotropin releasing hormone in the treatment of precocious puberty. Endocr Rev, 7, 24

    Article  PubMed  CAS  Google Scholar 

  8. Meisels, A (1967). The maturation value. Acta Cytol, 11, 249

    PubMed  CAS  Google Scholar 

  9. Greulich, WW, and Pyle, SI (1959). “Radiographic atlas of skeletal development of the hand and wrist”. 2nd Edition, (Stanford University Press, California)

    Google Scholar 

  10. Tanner, JM, Whitehouse, RH, Cameron, N, Marshall, WA, Healy MJR, and Goldstein, H (1983). “Assessment of skeletal maturity and prediction of adult height (TW2 Method)”. (Academic Press, New York)

    Google Scholar 

  11. Bayley, N, and Pinneau, ST (1952). Tables for predicting adult height from skeletal age, revised for use with the Greulich-Pyle hand standards. J Pediatr, 40, 432

    Google Scholar 

  12. Zachmann, M, Sobradillo, B, Frank, M, Frisch, H, and Prader, A (1978) Bayley-Pineau, Roche-Wainer-Thiessen and Tanner height predictions in normal children and in patients with various pathologic conditions. J Pediatr, 93, 749

    Article  PubMed  CAS  Google Scholar 

  13. Tanner, JM, and Davies, PSW (1985) Clinical longitudinal standards for height and height velocity for North American children. J Pediatr, 107, 317

    Article  PubMed  CAS  Google Scholar 

  14. Pescovitz, OH, Comite, F, Hench, K, Barnes, K, McNemar, A, Foster, C, Kenigsberg, D, Loriaux, DL and Cutler, GB (1986). The NIH experience with precocious puberty: Diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy. J Pediatr, 108, 47

    Article  PubMed  CAS  Google Scholar 

  15. Luder, AS, Holland, FJ, Costigan, DC, Jenner, MR, Wielgosz, G, and Fazekas, ATA (1984). Intranasal and subcutaneous treatment of central precocious puberty in both sexes with a long-acting analogue of luteinizing hormone-releasing hormone. J Clin Endocrinol Metab, 58, 966

    Article  PubMed  CAS  Google Scholar 

  16. Kauli, R, Pertzelan, A, Ben-Zeev, Z, Lewin, RP, Kaufman, H, Schally, AM, Schally, AV and Laron, Z (1984). Treatment of precocious puberty with LHRH analogue in combination with cyproterone acetate — further experience. Clin Endocrinol, 20, 377

    Article  CAS  Google Scholar 

  17. Styne, DM, Harris, DA, Egli, CA, Conte, FA, Kaplan, SL, Rivier, J, Vale, W and Grumbach, MM (1986). Treatment of true precocious puberty with a potent luteinizing hormone- releasing factor agonist: Effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis. J Clin Endocrinol Metab, 61, 142

    Article  Google Scholar 

  18. Roger, M, Chaussain, JL, Berlier, P, Bost, M, Canlorbe, P, Colle, M, Francois, R, Garandeau, P, Lahlou, N, Morel, Y and Schally, AV (1986). Long-term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-Luteinizing Hormone-Releasing hormone microcapsules. J Clin Endocrinol Metab, 62, 670

    Article  PubMed  CAS  Google Scholar 

  19. Comite, F, Cassorla, F, Barnes, KM, Hench, KD, Dwyer, A, Skerda, MC, Loriaux, DL, Cutler, GB and Pescowitz, OH (1986). Luteinizing hormone-releasing hormone analogue therapy for central precocious puberty. Long-term effect on somatic growth, bone maturation, and predicted height. JAMA, 255, 2613

    Article  PubMed  CAS  Google Scholar 

  20. Shuttleworth FK (1939). The physical and mental growth of girls and boys age six to nineteen in relation to age at maximum growth. Monogr Soc Res Child Dec, Vol. 4, No.3, Serial No. 22

    Google Scholar 

  21. Bayley, N (1956). Growth curves of height and weight by age for boys and girls, scaled according to physical maturity. J Pediatr, 48, 187

    Article  PubMed  CAS  Google Scholar 

  22. Tanner, JM, Whitehouse, RH, and Takaishi, M (1965). Standards from birth to maturity for height, weight, height velocity: British Children. Part I: Arch Dis Child, 41, 454

    Article  Google Scholar 

  23. Tanner, JM, Whitehouse, RH and Takaishi, M (1965). Standards from birth to maturity for height, weight, height velocity: British Children. Part II: Arch Dis Child, 41, 613

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Kluwer Academic Publishers

About this chapter

Cite this chapter

Boepple, P.A. et al. (1990). Growth Patterns and Skeletal Maturation During Sex Steroid Suppression and Reactivation in Central Precocious Puberty. In: Vickery, B.H., Lunenfeld, B. (eds) GnRH Analogues in Cancer and Human Reproduction. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0725-6_7

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-0725-6_7

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6811-6

  • Online ISBN: 978-94-009-0725-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics